Company Overview
PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
Recent News
PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer
Stock Overview
Symbol
PMCB
Exchange
OTCQB
Market Cap
Last Price
$
52-Week Range
$ - $
Investor Relations
PharmaCyte Biotech, Inc.
Investor Relations Department
T: 917-595-2856
Info@PharmaCyte.com